Literature DB >> 15735926

Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma.

Sercan Aksoy, Huseyin Abali, Saadettin Kiliçkap, Nilüfer Güler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15735926     DOI： 10.1007/s11060-004-1725-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  10 in total

1.  Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases.

Authors:  C Christodoulou; D Bafaloukos; P Kosmidis; E Samantas; A Bamias; P Papakostas; A Karabelis; C Bacoyiannis; D V Skarlos
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

Review 2.  Intracranial extraskeletal mesenchymal chondrosarcoma: case report.

Authors:  K D Bingaman; C H Alleyne; J J Olson
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

Review 3.  Current and future developments in the use of temozolomide for the treatment of brain tumours.

Authors:  R Stupp; M Gander; S Leyvraz; E Newlands
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

Review 4.  Meningeal chondrosarcomas, a review of 31 patients.

Authors:  R B Forbes; M S Eljamel
Journal:  Br J Neurosurg       Date:  1998-10       Impact factor: 1.596

Review 5.  Chondrosarcomas of the skull base: review of the literature and report of two cases.

Authors:  A D Rapidis; G Archondakis; D Anteriotis; C A Skouteris
Journal:  J Craniomaxillofac Surg       Date:  1997-12       Impact factor: 2.078

6.  Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Authors:  Roger Stupp; Pierre-Yves Dietrich; Sandrine Ostermann Kraljevic; Alessia Pica; Ivan Maillard; Phillipe Maeder; Reto Meuli; Robert Janzer; Gianpaolo Pizzolato; Raymond Miralbell; François Porchet; Luca Regli; Nicolas de Tribolet; René O Mirimanoff; Serge Leyvraz
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases.

Authors:  D Antonadou; M Paraskevaidis; G Sarris; N Coliarakis; I Economou; P Karageorgis; N Throuvalas
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

Review 8.  Intracranial chondrosarcoma: review of the literature and report of 15 cases.

Authors:  A G Korten; H J ter Berg; G H Spincemaille; R T van der Laan; A M Van de Wel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

9.  Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.

Authors:  S R Patel; M A Burgess; N E Papadopoulos; K A Linke; R S Benjamin
Journal:  Am J Clin Oncol       Date:  1995-04       Impact factor: 2.339

10.  Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomas.

Authors:  J H Edmonson; E T Creagan; L K Kvols; R L Richardson; J Rubin; S J Green
Journal:  Med Pediatr Oncol       Date:  1984
  10 in total
  2 in total

1.  Cranial chondrosarcoma and recurrence.

Authors:  Orin G Bloch; Brian J Jian; Isaac Yang; Seunggu J Han; Derick Aranda; Brian J Ahn; Andrew T Parsa
Journal:  Skull Base       Date:  2010-05

Review 2.  A systematic review of intracranial chondrosarcoma and survival.

Authors:  Orin G Bloch; Brian J Jian; Isaac Yang; Seunggu J Han; Derick Aranda; Brian J Ahn; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-09-30       Impact factor: 1.961
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.